428 related articles for article (PubMed ID: 12519616)
1. Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma.
Walters EH; Walters JA; Gibson PW
Cochrane Database Syst Rev; 2002; 2002(4):CD003901. PubMed ID: 12519616
[TBL] [Abstract][Full Text] [Related]
2. Inhaled long acting beta agonists for stable chronic asthma.
Walters EH; Walters JA; Gibson MD
Cochrane Database Syst Rev; 2003; (4):CD001385. PubMed ID: 14583933
[TBL] [Abstract][Full Text] [Related]
3. Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid.
Walters EH; Gibson PG; Lasserson TJ; Walters JA
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD001385. PubMed ID: 17253458
[TBL] [Abstract][Full Text] [Related]
4. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
Appleton S; Smith B; Veale A; Bara A
Cochrane Database Syst Rev; 2000; (2):CD001104. PubMed ID: 10796594
[TBL] [Abstract][Full Text] [Related]
5. Long acting beta-agonists versus theophylline for maintenance treatment of asthma.
Shah L; Wilson AJ; Gibson PG; Coughlan J
Cochrane Database Syst Rev; 2003; (3):CD001281. PubMed ID: 12917905
[TBL] [Abstract][Full Text] [Related]
6. Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease.
Appleton S; Poole P; Smith B; Veale A; Lasserson TJ; Chan MM
Cochrane Database Syst Rev; 2006 Jul; (3):CD001104. PubMed ID: 16855959
[TBL] [Abstract][Full Text] [Related]
7. Long-acting beta2-agonists versus theophylline for maintenance treatment of asthma.
Tee AK; Koh MS; Gibson PG; Lasserson TJ; Wilson AJ; Irving LB
Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD001281. PubMed ID: 17636663
[TBL] [Abstract][Full Text] [Related]
8. Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.
Sestini P; Renzoni E; Robinson S; Poole P; Ram FS
Cochrane Database Syst Rev; 2002; (4):CD001495. PubMed ID: 12519559
[TBL] [Abstract][Full Text] [Related]
9. Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews.
Cates CJ; Wieland LS; Oleszczuk M; Kew KM
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD010314. PubMed ID: 24504983
[TBL] [Abstract][Full Text] [Related]
10. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
O'Shea O; Stovold E; Cates CJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD007694. PubMed ID: 33852162
[TBL] [Abstract][Full Text] [Related]
11. Long acting beta-agonists versus theophylline for maintenance treatment of asthma.
Wilson AJ; Gibson PG; Coughlan J
Cochrane Database Syst Rev; 2000; (2):CD001281. PubMed ID: 10796631
[TBL] [Abstract][Full Text] [Related]
12. Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma.
Welsh EJ; Cates CJ
Cochrane Database Syst Rev; 2010 Sep; 2010(9):CD008418. PubMed ID: 20824877
[TBL] [Abstract][Full Text] [Related]
13. Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease.
Nannini L; Lasserson TJ; Poole P
Cochrane Database Syst Rev; 2003; (4):CD003794. PubMed ID: 14583994
[TBL] [Abstract][Full Text] [Related]
14. Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease.
Appleton S; Jones T; Poole P; Pilotto L; Adams R; Lasserson TJ; Smith B; Muhammad J
Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD006101. PubMed ID: 16856113
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of salmeterol and formoterol in patients with severe asthma.
Nightingale JA; Rogers DF; Barnes PJ
Chest; 2002 May; 121(5):1401-6. PubMed ID: 12006420
[TBL] [Abstract][Full Text] [Related]
16. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
[TBL] [Abstract][Full Text] [Related]
17. Regular treatment with salmeterol for chronic asthma: serious adverse events.
Cates CJ; Cates MJ
Cochrane Database Syst Rev; 2008 Jul; (3):CD006363. PubMed ID: 18646149
[TBL] [Abstract][Full Text] [Related]
18. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
Spencer S; Evans DJ; Karner C; Cates CJ
Cochrane Database Syst Rev; 2011 Oct; (10):CD007033. PubMed ID: 21975759
[TBL] [Abstract][Full Text] [Related]
19. Regular treatment with formoterol for chronic asthma: serious adverse events.
Cates CJ; Cates MJ
Cochrane Database Syst Rev; 2012 Apr; 4(4):CD006923. PubMed ID: 22513944
[TBL] [Abstract][Full Text] [Related]
20. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
Spencer S; Karner C; Cates CJ; Evans DJ
Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD007033. PubMed ID: 22161409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
